If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Congestive Heart Failure Class IV
Tirzepatide has not been studied in people with class IV congestive heart failure.
There is no information on the use of tirzepatide in patients with a history of class IV congestive heart failure because patients were excluded from tirzepatide clinical trials if they had a history of class IV congestive heart failure.
Date of Last Review: March 22, 2021